Decibel Therapeutics

Developer of new medicines to protect, repair and restore hearing capacity

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups62 employees language decibeltx.com

Registered entities

Innovation

35 patent families (12 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 2,170 times.

YearFilings
20171
20181
20193
20209
202116
202218
202318
202421
202518
202610

Investor mix

18 investors on record; lead investors include Orbimed; 1 has since exited.

Investor typeCountShare
Venture capital1267%
Other / undisclosed633%
Coming soon